Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

NCT01181960 · clinicaltrials.gov ↗

COMPLETED

Status

1066

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: Risperidone long acting injectable - New Starts
DRUG: Risperidone long acting injectable - Continuous Users
DRUG: Paliperidone Palmitate -New and Continuous Users
DRUG: Other Antipsychotics - New Starts

Sponsor

Janssen Scientific Affairs, LLC